TIL Technology

Application of TIL

Steven A. Rosenberg, MD on Adoptive T-Cell Immunotherapy in Melanoma

Steven A. Rosenberg, MD, Chief Surgery Branch at National Cancer Institute describes extraordinary clinical outcomes in patients treated with adoptive cellular immunotherapy, using cancer-specific activated T cells.